Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-03-05FDA Approved: CIPROFLOXACIN — Original Application (Chartwell RX, LLC)
FDA approved the original application for ciprofloxacin (generic) by Chartwell RX, LLC.
-
FDA approval · 2014-01-07FDA Approved: NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE — Supplemental Application (Alvogen Inc.)
FDA approved a supplemental application for Nitrofurantoin monohydrate/macrocrystalline submitted by Alvogen Inc.
-
FDA approval · 2013-11-04FDA Approved: NITROFURANTOIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for nitrofurantoin from Rising Pharma Holdings, Inc.
-
FDA approval · 2013-09-06FDA Approved: NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE — Supplemental Application (Alvogen Inc.)
FDA approves a supplemental application for nitrofurantoin monohydrate/macrocrystalline submitted by Alvogen Inc., providing regulatory acti…
-
FDA approval · 2013-09-06FDA Approved: NITROFURANTOIN MACROCRYSTALS — Supplemental Application (Alvogen Inc.)
FDA approved a supplemental application for Nitrofurantoin Macrocrystals submitted by Alvogen Inc., marking an addition/adjustment to the pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-06-05FDA Approved: LEVOFLOXACIN — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's Original Application for levofloxacin (generic), granting clearance for a generic version of th…
-
FDA approval · 2013-04-25FDA Approved: CEFADROXIL — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for a generic cefadroxil product from Rising Pharma Holdings, Inc. (ANDA065349).
-
FDA approval · 2013-03-29FDA Approved: CEFIXIME — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for cefixime from Lupin Pharmaceuticals, Inc. to modify/extend its labeling and/or approval.
-
FDA approval · 2012-11-14FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Nitrofurantoin (Macrocrystals) from Aurobindo Pharma Limited, enabling continued marketing under…
-
FDA approval · 2012-11-14FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for nitrofurantoin macrocrystals from Aurobindo Pharma Limited, authorizing a generic version of the…
-
FDA approval · 2012-09-18FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Nitrofurantoin (Macrocrystals) by Aurobindo Pharma Limited.
-
FDA approval · 2012-09-18FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for nitrofurantoin macrocrystals by Aurobindo Pharma Limited, granting approval for this generic pro…
-
FDA approval · 2012-06-01FDA Approved: CEFIXIME — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' cefixime product under NDA203195 as a generic oral cephalosporin antibiotic.
-
FDA approval · 2012-03-30FDA Approved: LEVOFLOXACIN — Original Application (Chartwell RX, LLC)
FDA approved an original ANDA for Levofloxacin, a generic antibiotic, submitted by Chartwell RX, LLC. The approval enables a generic version…
-
FDA approval · 2012-02-17FDA Approved: CEFACLOR — Original Application (Azorian Pharma, LLC)
The FDA approved Azorian Pharma, LLC's original application for Cefaclor (generic) for treating susceptible bacterial infections including r…
-
FDA approval · 2012-01-20FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for amoxicillin and clavulanate potassium, authorizing the marketing of thi…
-
FDA approval · 2011-11-02FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
The FDA granted approval of a supplemental application for Nitrofurantoin (Macrocrystals) from Aurobindo Pharma Limited, establishing a gene…
-
FDA approval · 2011-10-26FDA Approved: MEROPENEM — Original Application (Fresenius Kabi USA, LLC)
FDA approves Fresenius Kabi USA, LLC's original application for Meropenem as an injectable generic antibiotic.
-
FDA approval · 2011-10-12FDA Approved: NITROFURANTOIN MACROCRYSTALS — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's supplemental application for nitrofurantoin macrocrystals, authorizing the marketing o…
-
FDA approval · 2011-10-12FDA Approved: NITROFURANTOIN MACROCRYSTALS — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Nitrofurantoin macrocrystals from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2011-06-15FDA Approved: TRIMETHOPRIM — Original Application (Novel Laboratories, Inc.)
FDA approved Novel Laboratories, Inc.'s original application for trimethoprim, establishing a generic supplier of the antibiotic.
-
FDA approval · 2011-05-11FDA Approved: NITROFURANTOIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original application for nitrofurantoin from Amneal Pharmaceuticals NY LLC, granting marketing approval for this generic pr…
-
FDA approval · 2011-02-22FDA Approved: CEPHALEXIN — Supplemental Application (AVKARE)
The FDA approved a supplemental application for Cephalexin from AvKare.
-
FDA approval · 2011-01-27FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for amoxicillin and clavulanate potassium (Hikma Pharmaceuticals USA Inc.), updating the product…
-
FDA approval · 2010-12-20FDA Approved: CEPHALEXIN — Original Application (AvPAK)
FDA approved the original application for Cephalexin (generic) from AvPAK under ANDA090836.